- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04587102
Whole Body Vibration Training for Diabetic Patients With Burn Injury
Whole Body Vibration Training for Diabetic Patients With Burn Injury: RCT
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Giza, Egypt, 2136
- Burn Unit at Om El Masrien Hospital
-
-
Nnjkjk
-
Giza, Nnjkjk, Egypt, 2136
- Zizi Mohammed Ibrahim Ali
-
-
-
-
-
Riyadh, Saudi Arabia, 2136
- Zizi Mohammed Ibrahim Ali
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- chronic lower limb burns injury for more than 6 months
- Total body surface area (TBSA) burnt ≤ 30%.;
Exclusion Criteria:
- cognitive or mentality dysfunctions,
- psychiatric conditions,
- fractures,
- pregnancy,
- cancer,
- severe vascular complications,
- inability to walk
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
ACTIVE_COMPARATOR: whole body viberation :group A
will receive low vibrational training in the form of whole body vibration for 8 weeks
|
vibration training in the form of whole body vibration for 20-30 minutes per session, 3 sessions per week for 8 weeks.
The vibration training was performed on a whole body vibration platform
Other Names:
balance exercises and resisted exercises
|
|
ACTIVE_COMPARATOR: control group (B)
control
|
balance exercises and resisted exercises
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Dynamic balance assessment
Time Frame: Change from Baseline at balance scores at 8 weeks
|
Biodex Balance System was used to measure the dynamic balance of each patient in both groups (A and B) before and after 8 weeks of treatment. The system has a movable balance platform that permits about 20◦ tilt in 360◦ range, and is interfaced with computer software for objective balance assessment. It measures the ability of the patient to control the platform's tilting angle, which is quantified as a variation from the center, as well as the deflection degree over time at different stability levels |
Change from Baseline at balance scores at 8 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
The Activities-specific Balance
Time Frame: Change from Baseline at Activities-specific Balance scores at 8 weeks
|
A short,six-question version of the Activities-specific Balance scale, the Activities-specific Balance scale.
Individuals report their balance confidence in six tasks: standing on tiptoes and reaching for something overhead, standing on a chair to reach for something, being bumped into by people while walking through a mall, stepping off an escalator holding onto the railing, stepping off an escalator without holding onto the railing, and walking on an icy sidewalk ABC scores range between 0% and 100%, with higher scores indicating better balance confidence
|
Change from Baseline at Activities-specific Balance scores at 8 weeks
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: ZIZI MOHAMMED I ALI, Cairo University
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- VIYOBURN
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.